169 related articles for article (PubMed ID: 21444322)
1. Preliminary evidence of hippocampal damage in chronic users of ecstasy.
den Hollander B; Schouw M; Groot P; Huisman H; Caan M; Barkhof F; Reneman L
J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):83-5. PubMed ID: 21444322
[TBL] [Abstract][Full Text] [Related]
2. Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.
Daumann J; Fischermann T; Heekeren K; Henke K; Thron A; Gouzoulis-Mayfrank E
Psychopharmacology (Berl); 2005 Aug; 180(4):607-11. PubMed ID: 15372137
[TBL] [Abstract][Full Text] [Related]
3. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
[TBL] [Abstract][Full Text] [Related]
4. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
Gouzoulis-Mayfrank E; Thimm B; Rezk M; Hensen G; Daumann J
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
[TBL] [Abstract][Full Text] [Related]
5. Memory deficits associated with recreational use of "ecstasy" (MDMA).
Morgan MJ
Psychopharmacology (Berl); 1999 Jan; 141(1):30-6. PubMed ID: 9952062
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users.
Fox HC; McLean A; Turner JJ; Parrott AC; Rogers R; Sahakian BJ
Psychopharmacology (Berl); 2002 Jul; 162(2):203-14. PubMed ID: 12110998
[TBL] [Abstract][Full Text] [Related]
7. Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naïve controls.
Hoshi R; Mullins K; Boundy C; Brignell C; Piccini P; Curran HV
Psychopharmacology (Berl); 2007 Oct; 194(3):371-9. PubMed ID: 17605005
[TBL] [Abstract][Full Text] [Related]
8. Differences in prefrontal blood oxygenation during an acute multitasking stressor in ecstasy polydrug users.
Roberts CA; Wetherell MA; Fisk JE; Montgomery C
Psychol Med; 2015 Jan; 45(2):395-406. PubMed ID: 25066866
[TBL] [Abstract][Full Text] [Related]
9. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?
Morgan MJ; McFie L; Fleetwood H; Robinson JA
Psychopharmacology (Berl); 2002 Jan; 159(3):294-303. PubMed ID: 11862362
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological indices of altered working memory processes in long-term ecstasy users.
Nulsen C; Fox A; Hammond G
Hum Psychopharmacol; 2011 Oct; 26(7):488-97. PubMed ID: 21953632
[TBL] [Abstract][Full Text] [Related]
11. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study.
Rodgers J; Buchanan T; Scholey AB; Heffernan TM; Ling J; Parrott AC
J Psychopharmacol; 2003 Dec; 17(4):389-96. PubMed ID: 14870950
[TBL] [Abstract][Full Text] [Related]
12. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
Medina KL; Shear PK; Corcoran K
J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
[TBL] [Abstract][Full Text] [Related]
13. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug.
Fox HC; Parrott AC; Turner JJ
J Psychopharmacol; 2001 Dec; 15(4):273-81. PubMed ID: 11769821
[TBL] [Abstract][Full Text] [Related]
14. Event related potential (ERP) evidence for selective impairment of verbal recollection in abstinent recreational methylenedioxymethamphetamine ("Ecstasy")/polydrug users.
Burgess AP; Venables L; Jones H; Edwards R; Parrott AC
Psychopharmacology (Berl); 2011 Aug; 216(4):545-56. PubMed ID: 21390504
[TBL] [Abstract][Full Text] [Related]
15. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users.
Thomasius R; Petersen K; Buchert R; Andresen B; Zapletalova P; Wartberg L; Nebeling B; Schmoldt A
Psychopharmacology (Berl); 2003 Apr; 167(1):85-96. PubMed ID: 12632248
[TBL] [Abstract][Full Text] [Related]
16. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
Halpern JH; Sherwood AR; Hudson JI; Gruber S; Kozin D; Pope HG
Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxicity of methylenedioxyamphetamines (MDMA; ecstasy) in humans: how strong is the evidence for persistent brain damage?
Gouzoulis-Mayfrank E; Daumann J
Addiction; 2006 Mar; 101(3):348-61. PubMed ID: 16499508
[TBL] [Abstract][Full Text] [Related]
18. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy?
Kish SJ
Pharmacol Biochem Behav; 2002 Apr; 71(4):845-55. PubMed ID: 11888575
[TBL] [Abstract][Full Text] [Related]
19. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
[TBL] [Abstract][Full Text] [Related]
20. Cognitive disorders after sporadic ecstasy use? A case report.
Ruis C; Postma A; Bouvy W; van der Ham I
Neurocase; 2015; 21(3):351-7. PubMed ID: 24606066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
